EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic analysis and pneumococcal population dynamics across PCV implementation in South Korea, 1997–2023

Jeong-Ih Shin, Sung-Yeon Cho, Jiyon Chu, Chulmin Park, Minho Lee, Joon Young Song, Seung-Hyun Jung, Dong-Gun Lee

Microbial Genomics · 17.07.2025 · 11 (7)

DOI: 10.1099/mgen.0.001433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, erschienen am 17.07.2025. Verfasst von Jeong-Ih Shin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Pneumococcal Infections, Pneumococcal Vaccines. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptococcus pneumoniae , a clinically significant pathogen, causes invasive diseases in children and older adults. Pneumococcal conjugate vaccines (PCVs) have substantially reduced the incidence of vaccine serotype (VT) pneumococcal diseases. However, serotype replacement, characterized by the emergence of non-vaccine serotypes (NVTs), presents a persistent challenge to disease prevention. To address this, we analysed 236 pneumococcal isolates collected in South Korea between 1997 and 2023, spanning both pre- and post-PCV13 periods. Whole-genome sequencing was performed to assess serotypes, antimicrobial resistance, virulence factors and global pneumococcal sequence clusters (GPSCs). Capsular switching events and the relationships among pneumococcal lineages, serotypes and disease invasiveness were also evaluated. Among the 37 identified serotypes, NVTs such as 23A, 15B/15C and 10A were dominant post-PCV13. Serotype 10A, associated with invasive pneumococcal diseases (IPDs), belonged to GPSC634-ST11189 and showed elevated minimum inhibitory concentrations for β -lactams. Capsular switching events were observed between VTs and NVTs, highlighting the adaptability of pneumococcal populations. Antimicrobial non-susceptibility was highest for azithromycin (82.7%), followed by tetracycline (76.5%) and co-trimoxazole (70.4%), with higher rates observed in the post-PCV13 period. Notably, amoxicillin ( P =0.049) and meropenem ( P =0.002) showed significant non-susceptibility in the post-PCV13 period. Virulence factors pspA and pfbA were associated with IPDs, while pilus islet PI-1-related genes were more frequent in non-invasive cases. These findings underscore the importance of genomic surveillance to monitor pneumococcal population dynamics and inform public health strategies. The inclusion of serotype 10A in the recently approved PCV20 offers promise for further reducing the global burden of IPDs, including in South Korea.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pneumoniaePneumococcal InfectionsPneumococcal VaccinesRepublic of KoreaHumansSerogroupWhole Genome SequencingAnti-Bacterial AgentsVirulence FactorsGenome, BacterialChildMicrobial Sensitivity TestsGenomicsChild, PreschoolAgedAdultInfantMiddle Aged

Stichwörter der Autor:innen

Streptococcus pneumoniaeantimicrobial resistanceglobal pneumococcal sequence clusterpneumococcal conjugate vaccinewhole-genome sequencing

Substanzen

Pneumococcal VaccinesAnti-Bacterial AgentsVirulence Factors13-valent pneumococcal vaccine

Autor:innen und Institutionen

  • Department of Medical Sciences, Graduate School of The Catholic University of Korea, Seoul, Republic of Korea.
  • Catholic Research Institute for Human Genome Polymorphism, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Vaccine Bio Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Internal Medicine, Division of Infectious Diseases, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Catholic Hematology Hospital, Seoul St. Mary's Hospital, Seoul, Republic of Korea.
  • Department of Life Science, Dongguk University-Seoul, Seoul, Republic of Korea.

Förderung

  • Ministry of Health and Welfare

Zitieren

APA

Shin, J. I., Cho, S. Y., Chu, J., Park, C., Lee, M., Song, J. Y., Jung, S. H., & Lee, D. G. (2025). Genomic analysis and pneumococcal population dynamics across PCV implementation in South Korea, 1997–2023. Microbial Genomics, 11(7). https://doi.org/10.1099/mgen.0.001433

Vancouver

Shin JI, Cho SY, Chu J, Park C, Lee M, Song JY, et al. Genomic analysis and pneumococcal population dynamics across PCV implementation in South Korea, 1997–2023. Microbial Genomics. 2025;11(7). doi:10.1099/mgen.0.001433

BibTeX
@article{Shin2025,
  author = {Shin, Jeong-Ih and Cho, Sung-Yeon and Chu, Jiyon and Park, Chulmin and Lee, Minho and Song, Joon Young and Jung, Seung-Hyun and Lee, Dong-Gun},
  title = {Genomic analysis and pneumococcal population dynamics across PCV implementation in South Korea, 1997–2023},
  journal = {Microbial Genomics},
  year = {2025},
  volume = {11},
  number = {7},
  doi = {10.1099/mgen.0.001433}
}
Kostenlos starten →